Skip to main content
. Author manuscript; available in PMC: 2022 Jun 15.
Published in final edited form as: J Immunol. 2021 Jun 15;206(12):2775–2783. doi: 10.4049/jimmunol.2100082

Figure 1. Distinct Mechanisms by which CXCR5+CD8+ T Cell Subsets Impact Humoral Immunity.

Figure 1.

CXCR5+CD8+ T cell subsets are reported to mediate different effects upon antibody production. Antibody-enhancing CXCR5+CD8+ T cells express PD-1, ICOS, CD40L, and cytokines such as IFN-γ and IL-21. In vitro co-culture studies suggest that antibody-enhancing CXCR5+CD8+ T cells interact directly with antibody-producing B cells, or synergistically with CD4+ TFH cells, to increase antibody production by antibody secreting cells (ASC). In contrast, one subset of CXCR5+CD8+ T cells that protects against autoimmunity is Qa-1 restricted (CD44+ICOSL+PD-1+CD122+Ly49+) and exerts cytotoxic killing of autoreactive CD4+ TFH cells resulting in decreased autoantibody production. Another subset of antibody-suppressor CXCR5+CD8+ T cells (CD44+ICOSLPD-1IFN-γ+) is MHC-I restricted, antigen-specific, and directly mediates killing of allo-primed IgG+ B cells resulting in reduction of alloantibody production after transplant.